Anocca
  • About us
    • Introduction
    • Company leadership
  • Technologies
    • Introduction
    • Challenge
    • Engineered Immunity
    • Differentiation
    • Manufacturing
  • Pipeline
  • Partnering
  • Newsroom
    • Press releases
    • Anocca in the news
    • Reports & Regulatory press releases
  • Event calendar
  • Careers
Select Page
Michael Kalos

Michael Kalos

Jun 13, 2022

Klas Kärre

Klas Kärre

Aug 22, 2018

Mike Nishimura

Mike Nishimura

Aug 22, 2018

Rolf Kiessling

Rolf Kiessling

Aug 20, 2018

My own excerpt

Adnane Achour

Adnane Achour

Aug 20, 2018

Latest news

  • Press release Dec 21, 2022

    Anocca säkrar 25 miljoner euro från Europeiska investeringsbanken (EIB) för att stödja klinisk utveckling av nästa generations T-cellsterapier för cancer

    Södertälje, 21 december 2022 – Anocca, ett helt integrerat bioteknikföretag för utveckling av T-cellsbehandlingar, meddelade …

    Read more »

  • Press release Dec 21, 2022

    Anocca secures EUR 25 million from the European Investment Bank (EIB) to support clinical development of next-generation T-cell therapies for cancer

    Södertälje, Sweden, 21 December 2022 – Anocca, a fully integrated cell therapy biotechnology company, today …

    Read more »

  • Press release Apr 7, 2022

    Renowned Immunotherapy Expert Dr. Michael Kalos joins Anocca’s Scientific Advisory Board

    Södertälje, Sweden, 7th April 2022 – Anocca, a biotechnology company using its precision biology platforms …

    Read more »

Anocca AB

Forskargatan 20C
151 36 Södertälje, Sweden
+46 (0)8 410 807 50

info@anocca.com

Show on map

Direct Contact

Business Development & Partnering
bd@anocca.com

Science & Technology
sci@anocca.com

Talent & Recruitment
jobs@anocca.com

Visit us on LinkedIn

Copyright © 2020 Anocca AB
Registration number 556946-2384

Anocca Privacy Policy

  • Anocca AB

    General enquires
    info@anocca.com

    Business Development & Partnering
    bd@anocca.com

    Science & Technology
    sci@anocca.com

    Visit us on LinkedIn